A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid Lobectomy

What this Trial Is About

This research aims to compare same-day discharge with the usual overnight stay after thyroid lobectomy, focusing on differences in patient preferences, safety outcomes, and economic and resource impacts. It particularly evaluates symptom severity using the MD Anderson Symptom Inventory - Thyroid MDASI-Thyroid at 24 hours and 2 weeks post-procedure, along with monitoring complications such as hematoma, emergency visits, readmissions, pain levels, and mortality. Morphine use during the two weeks after surgery is also assessed. Participants will complete surveys about their symptoms before surgery, one day after surgery, and two weeks later, mainly through electronic methods. At the pre-surgery visit, patients are randomly assigned to either same-day discharge or overnight hospital stay for observation. Monitoring continues for up to one month post-surgery, including possible virtual or in-person check-ins to discuss medication use and health needs. During the study, participants will complete symptom surveys and attend standard postoperative visits around two weeks after surgery. The research team tracks adverse events graded by national criteria over an average of one year. Follow-ups may include phone or in-person visits at one month to assess recovery and medication use. The total duration of involvement includes pre-surgery, immediate post-surgery, and one month of monitoring.

A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid Lobectomy